Global Meperidine (Demerol) Market Continues To Gain Significant Momentum With Elite Pharmaceuticals Inc. Launching Generic Methadone Hydrochloride 5mg And 10 Mg Tablets

 

Meperidine (Demerol) market

Meperidine is one of many narcotic pain medicines that can be prescribed to relieve muscle spasms, which can come with the recommendation of an arthritis specialist. It acts as an anticonvulsant and is used to alleviate the severe symptoms of myasthenia gravis, which is the result of a lack of muscle strength. It was first developed to treat muscular dystrophy, although it is now being used more widely for muscle and joint pain due to a variety of different causes including carpal tunnel syndrome and tendonitis.

Increasing prevalence of cancer and other pain-related diseases is expected to drive growth of the global meperidine (Demerol) market. According to the World Health Organization (WHO), in 2018, around 9.6 million deaths were reported due to cancer globally, of which 2.09 million cases were due to lung cancer. Cancer is one of those diseases that can cause severe chronic pain to the patient, where physicians prefer pharmacological methods to treat the pain and reduce the suffering. For patients suffering intractable chronic pain where conventional treatment methods are ineffective, opioid drug therapy is mainly used, in order to get relief from continuous pain. Generally, patients prefer opioid drugs such as meperidine for this treatment. Hence, such factors are expected to drive growth of the global meperidine (Demerol) market. Furthermore, increasing number of surgical procedures performed worldwide is expected to propel the global meperidine (Demerol) market growth in the near future. According to Eurostat, in 2017, around 1.4 million cesarean sections were performed in the European Union (EU).

Challenges such as increased addiction to opioids and the availability of alternative opioid medications are expected to restrain growth of the global meperidine (Demerol) market. Besides, side effects such as possible generalized seizures is expected to hinder the global meperidine (Demerol) market growth in the near future. Among regions, North America is expected to witness significant growth in the global meperidine (Demerol) market. This is owing to increasing prevalence of osteoarthritis across the region. According to the Centers for Disease Control and Prevention (CDC), in 2018, over 30 million people suffered from osteoarthritis in the U.S. Moreover, Asia Pacific is expected to register a robust growth rate, owing to the presence of a massive consumer base in the region.

Key companies involved in the global meperidine (Demerol) market are Vintage Pharmaceuticals, Inc. Pfizer, Inc., Epic Pharma, Inc., Hikma Pharmaceuticals USA Inc., and Epic Pharma, Inc.

For instance, in November 2018, Elite Pharmaceuticals Inc., a provider of abuse-deterrent opioids, launched generic methadone hydrochloride 5mg and 10 mg tablets by Glenmark Pharmaceuticals, Inc., USA.

Comments

Popular posts from this blog

Bourbon Whiskey Is the Most Popular Whiskey in America and In Many Other Countries around the World

Viral Vectors And Plasmid DNA Manufacturing Market Is Gaining Major Traction With Oxford Biomedica Plc Entering Into A 3-Year Agreement With Boehringer Ingelheim For The Manufacture And Supply Of Various Types Of Viral Vectors

Hard Surface Flooring Market Is Expected To Witness Robust Growth As Mohawk Industries Introduces Newly Imagined 30,000-Square Foot Floor Space At The International Surface Event (TISE)